Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
about
Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic ReviewEngaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
P2860
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Positive impact of hepatitis C ...... ment for injecting drug users.
@en
Positive impact of hepatitis C virus
@nl
type
label
Positive impact of hepatitis C ...... ment for injecting drug users.
@en
Positive impact of hepatitis C virus
@nl
prefLabel
Positive impact of hepatitis C ...... ment for injecting drug users.
@en
Positive impact of hepatitis C virus
@nl
P2093
P2860
P50
P1433
P1476
Positive impact of hepatitis C ...... ment for injecting drug users.
@en
P2093
ANRS-CO-13-HEPAVIH Study Group
Dominique Salmon-Céron
Karine Lacombe
Lionel Fugon
Maria Patrizia Carrieri
Maria Winnock
Philippe Sogni
P2860
P304
P356
10.1111/J.1360-0443.2011.03608.X
P407
P577
2011-10-12T00:00:00Z